Chen Z, Lu X, Huang R
Department of Pathology, Xinjiang Medical College, Ulumqi.
Zhonghua Zhong Liu Za Zhi. 1997 Jan;19(1):69-71.
Detection of tumor micrometastases in resected lymph nodes of cancer patients to obtain more reliable information concerning nodal status and its clinicopathological importance.
Paraffin blocks of 3,715 resected lymph nodes from 350 Stage I cancer patients, suffering from NSCLC (n = 94), breast cancer (n = 112), esophageal cancer (n = 115), and vulvar cancer (n = 29), were re-examined by immunohisto-chemical staining, using monoclonal anti-cyokeratins (AE1/AE3), anti-EMA, and polyclonal anti-keratins antibodies.
Occult nodal metastases was observed in 113 of 350 cancer patients (32.5%), and in 203 of 3,715 lymph nodes examined. The positive rates both in patients and in lymph nodes were higher in NSCLC than in others. Occult nodal metastasis was seen in 58% of pulmonary squamous-cell carcinomas and 53.8% of adenocarcinomas, while it was seen in 22.5% of esophageal and 10.3% of vulval squamous-cell carcinomas, and in 27.7% of breast adenocarcinomas (P < 0.05). Follow up of a fraction of breast cancer patients showed that the prognosis of patients with positive nodes was worse than that in patients with negative nodes (P < 0.05).
The data suggested that the immunohistochemical technique can significantly facilitate the detection of micrometastatic tumor cells in lymph nodes. The frequency of occult lymph node metastasis may have significant impact on the prognosis of cancer patients.
检测癌症患者切除淋巴结中的肿瘤微转移,以获取有关淋巴结状态及其临床病理重要性的更可靠信息。
对350例I期癌症患者(其中非小细胞肺癌94例、乳腺癌112例、食管癌115例、外阴癌29例)切除的3715个淋巴结石蜡块,采用单克隆抗细胞角蛋白(AE1/AE3)、抗上皮膜抗原(EMA)和多克隆抗角蛋白抗体进行免疫组织化学染色复查。
350例癌症患者中有113例(32.5%)发现隐匿性淋巴结转移,3715个检查淋巴结中有203个发现隐匿性淋巴结转移。非小细胞肺癌患者及淋巴结的阳性率均高于其他癌症。肺鳞状细胞癌隐匿性淋巴结转移率为58%,腺癌为53.8%,而食管鳞状细胞癌为22.5%,外阴鳞状细胞癌为10.3%,乳腺腺癌为27.7%(P<0.05)。对部分乳腺癌患者的随访显示,淋巴结阳性患者的预后比阴性患者差(P<0.05)。
数据表明免疫组织化学技术可显著促进淋巴结中微转移肿瘤细胞的检测。隐匿性淋巴结转移频率可能对癌症患者的预后有显著影响。